EJTUNow
Member
- Joined
- Mar 25, 2013
- Messages
- 28
- Reason
- Learn about ALS
- Country
- US
- State
- North Carolina
- City
- Carteret
"They responded before they had to and provided us with a very aggressive trial"
Richard Garr, J.D., Director, CEO and President of Neuralstem, expressed particular thanks to the ALS community for their passionate participation in the February 2013 FDA hearing. "The outpouring of support... clearly had an impact which trickled down to the reviewers. They responded before they had to and provided us with a very aggressive trial, which of course is exactly what is needed for this most aggressive disease."
(from ALSWW)
we need more breakthroughs, consider joining us; ALSTUN
Richard Garr, J.D., Director, CEO and President of Neuralstem, expressed particular thanks to the ALS community for their passionate participation in the February 2013 FDA hearing. "The outpouring of support... clearly had an impact which trickled down to the reviewers. They responded before they had to and provided us with a very aggressive trial, which of course is exactly what is needed for this most aggressive disease."
(from ALSWW)
we need more breakthroughs, consider joining us; ALSTUN